跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,950 条关于
“T-MAXIMUM PHARMACEUTICAL Inc”
全部
61,950
临床试验
19,098
药物
6,489
机构
7,650
资讯
28,713
上个月
T-MAXIMUM's Universal CAR-T MT027 to Debut Brain Metastasis Data at WCLC 2026 as Intracranial Tumors Emerge as Solid Tumor CAR-T's Second Battlefield
9个月前
T-MAXIMUM's Allogeneic CAR-T Therapy MT027 Receives FDA Clearance for Phase II Glioblastoma Trial
去年
Ultragenyx's GTX-102 Shows Promise in Angelman Syndrome Phase 1/2 Trial
去年
Minghui Pharma's MHB018A Shows Promise in Thyroid Eye Disease Trial
去年
Experts Call for Paradigm Shift in Cancer Drug Dosing: Moving Beyond Maximum Tolerated Dose
上个月
Federal Appeals Court Revives 'Maximum Strength' Claims in Oral Phenylephrine Decongestant False Advertising Litigation
去年
CD7 CAR-T Cell Therapy Shows Promise in Relapsed/Refractory T-ALL
去年
Cyclopharm Secures Maximum 5-Year US Patent Extension for Technegas Lung Imaging Agent Through 2031
去年
Vir Biotechnology Announces Positive Results for Tobevibart and Elebsiran Combination Therapy in Chronic Hepatitis B
去年
Phase I Trial Establishes Maximum Tolerated Dose for Pegylated Liposomal Doxorubicin Plus Ifosfamide in Advanced Soft Tissue Sarcoma
第 1 页，共 2872 页
上一页
下一页
